Next Article in Journal
Investigating Flood Risks of Rainfall and Storm Tides Affected by the Parameter Estimation Coupling Bivariate Statistics and Hydrodynamic Models in the Coastal City
Next Article in Special Issue
Percent Body Fat-Related Disparities of Serum Ferritin on the Risk of Lipid Metabolism Abnormalities in Children and Adolescents
Previous Article in Journal
The Effectiveness of Interventions to Increase Participation and Physical Activities in Parks: A Systematic Review of the Literature
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Impacts of Educational Interventions with Support of Mobile App versus Booklet for Patients with Hypertension and Metabolic Syndrome: A Secondary Data Analysis

by
Eliza Mi Ling Wong
1,
Hon Lon Tam
2,
Angela Yee Man Leung
3,
Alice Siu Ping Cheung
3,
Ka Ching Cheung
3 and
Doris Yin Ping Leung
3,*
1
School of Nursing, Tung Wah College, Hong Kong SAR, China
2
The Nethersole School of Nursing, The Chinese University of Hong Kong, Hong Kong SAR, China
3
School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2022, 19(19), 12591; https://doi.org/10.3390/ijerph191912591
Submission received: 23 August 2022 / Revised: 22 September 2022 / Accepted: 30 September 2022 / Published: 2 October 2022

Abstract

:
Background: Hypertension comorbid with metabolic syndrome could increase the development of adverse cardiovascular events. Educational interventions were effective to improve outcomes in patients. Methods: This was a secondary data analysis of participants with hypertension. The original randomized controlled trial aimed to examine the effect of app and booklet versus control among individuals diagnosed with metabolic syndrome living in the community. A 30-min health education was provided to each participant. In addition to the education, the app group received a mobile app while the booklet group received a booklet. Data were collected at baseline, week 4, week 12, and week 24. Intention-to-treat principle was followed, and generalized estimating equations was employed for data analysis. Results: A total of 118 participants with hypertension and metabolic syndrome were extracted from the three-arm trial data. The sample size was 36, 42, and 40 in the app group, booklet group, and control group, respectively. Compared to the control group, the app group showed a significant reduction on body weight and waist circumference at week 24, while the total exercise and self-efficacy for exercise were increased at week 12 and week 24 but no significant findings were observed in the booklet group. Conclusions: The educational intervention supported with app was superior to the booklet support on the outcomes of body weight, waist circumference, total exercise, and self-efficacy for exercise among patients with hypertension and metabolic syndrome in the community.

1. Introduction

A person with metabolic syndrome (MetS) should have a cluster of cardiometabolic risk factors such as central obesity (defined as waist circumference with ethnicity-specific values) plus two of the follow factors or be receiving related treatment, such as dyslipidemia, insulin resistance, and hypertension [1]. Although the diagnostic criteria of MetS are different between professional institutions, it was estimated that over 1 billion people were having MetS worldwide [2,3]. The prevalence of MetS has been increasing, with prevalence of over 30% in the western population and about 22% in the Chinese population [2,4]. If MetS is not well controlled, it leads to coronary heart disease and stroke [5,6]. Regarding the diagnostic criteria of MetS, hypertension is raised concern. Hypertension is first among the risk factors to cause health burden worldwide that led to various adverse cardiovascular events, such as heart diseases and stroke, and attributed 10.8 million global deaths in 2019 [7,8]. The American Heart Association indicates that MetS amplifies the chance of developing adverse cardiovascular events [9].
Lifestyle modifications in terms of healthy diet and regular exercise are recognized important in the management of hypertension and MetS [1,3,10,11,12]. Educational interventions, such as health education and booklet, could effectively improve the adherence to lifestyle modifications [13,14,15]. With the popularity of smartphone ownership, mobile apps have been developed to provide support to health education [16,17]. These support program have proven effective to support for continuous care for patients with MetS or cardiac risks [17,18,19,20,21]. However, these reviews and studies focused on either hypertension or MetS. Patients with hypertension and MetS are concerned since they have higher chance of adverse cardiovascular events than other MetS patients without hypertension [5]. Up to our knowledge, there is no study examined the effect of app, booklet versus control on patients with hypertension and MetS. We intend to carry out a secondary data analysis to examine the outcomes for these group of patients.

Aims

The secondary data analysis aimed to examine the effect of an educational intervention using mobile app and booklet versus control group, and mobile app versus booklet on outcomes of body weight, total exercise, cardiometabolic profile (waist circumference, blood pressure, cholesterols, triacylglycerols, and fasting blood glucose), perceived stress, and exercise self-efficacy for patients with hypertension and MetS in the community.

2. Materials and Methods

This was a sub-group analysis of a three-arm randomized controlled trial (RCT). The aim of the original three-arm RCT was to compare the effect a lifestyle intervention using mobile app versus booklet for MetS patients living in the community. The trial has been registered in ClinicalTrials.gov with ID: NCT03778788, and the study protocol has been published elsewhere [22]. Eligible participants were randomly assigned to the app group, booklet group, and the control group in a ratio of 1:1:1 with outcome assessments at baseline (T1), week 4 (T2), week 12 (T3), and week 24 (T4).

2.1. Participants and Inclusion and Exclusion Criteria

Data were collected from August 2019 to December 2021 in Hong Kong. Participants were recruited at two community centers located near the participating university using convenience sampling. 368 people were screened, 264 of them had MetS and agreed to participate the study. 118 participants with hypertension and MetS were selected for this secondary data analysis. The sample size was 36, 42, and 40 in the app group, booklet group, and control group, respectively.

2.2. Intervention Material

The interventions for each group followed the published study protocol [22]. Self-efficacy theory and health belief model are the theoretical framework used to guide the development of interventions for app group and booklet group. Participants in the same group were called back in a day to receive a standard 30-min group health education related to healthy lifestyle delivered by a trained nurse. Brisk walking exercise was suggested in the education. Different intervention days were assigned to specific groups to minimize subject contamination.
App group. A research assistant (RA) assisted participants to install a MetS mobile app and explain the use of app after the health education. Then, the participants could read the same knowledge content as the booklet in the app. A membership area provided individual support for self-health monitoring, goal setting for their exercise plan and exercise record. 15 daily messages were delivered the participants to enhance their interest in the app intervention. Congratulatory remarks were provided if the participants completed their exercise goal, and an exercise reminder was sent if they did not enter the exercise record for two weeks.
Booklet group. The participants received a healthy lifestyle booklet and read it at home. The booklet covered the same content of the facts about MetS and advice on diet, exercise, medication, lifestyle, and stress management.
Control group. A placebo leaflet containing information on obesity and healthy lifestyle was delivered to the participants. For ethical reasons, the participants received the healthy lifestyle booklet after completion of the study.

2.3. Data Collection

The eligible participants signed the written consent before baseline assessment. Outcomes were assessed again at T2, T3, and T4. Two RAs collected data, one for baseline and one for the other three assessments after randomization. Both were blinded to the study allocation and received training for data collection, and the participants in each group were arranged on different date for follow-up assessments to avoid contamination.

2.4. Outcvome Variables

Details of primary outcome and secondary outcomes were described in the published study protocol [22]. In brief, body weight was the primary outcome that was measured by the same electronic weight scale. The secondary outcomes were described as follows.
Total exercise was measured by a modified version of the Godin-Shephard Leisure-Time Physical Activity Questionnaire (GSLTPAQ), which assessed the amount and difficulty of the exercises performed [23]. Cardiometabolic profile in terms of waist circumference, blood pressure, total cholesterol, high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, triacylglycerols, and fasting blood glucose were measured by validated monitor. Three-min step test was used to assess the participant’s cardiovascular functional endurance. The perceived stress scale (PSS-10), a 4-point Likert scale with 10 items, used to assess the participant’s stress [24]. The total scores range from 0 to 40 that a higher score indicates a higher level of stress. Exercise self-efficacy was measured by a validated scale, self-efficacy for exercise scale (SEE) [25]. The scale consists of 9 items with total scores range from 0 to 90. A high score indicates a high level of self-efficacy to do exercise. All of the primary outcome and secondary outcomes were measured at T1, T2, T3, and T4, except cardiometabolic profile and three-min step test were measured at T1 and T4 only.

2.5. Data Analysis

Data were analyzed using SPSS version 26. Baseline characteristics and outcome variables were compared between the three groups using chi-square tests for categorical variables or ANOVA for continuous variables. By following the intention-to-treat principle, generalized estimating equation (GEE) was adopted to compare the mean changes of the app group and booklet group to the control group in the continuous variables. All statistical tests were two-sided and a p-value < 0.05 was considered as statistical significance. Between-group effect size at T4, measured by Cohen’s d, on each outcome variable was determined according to the following: small = 0.2; moderate = 0.5; and large = 0.8 [26].

3. Results

3.1. Baseline Characteristics

Table 1 shows the sociodemographic and clinical characteristics of the participants among the three groups. The mean age was 65.72 ± 9.25 years. Most of the participants were female (n = 83, 70.33%), educated at secondary school and higher (n = 91, 77.12%), married (n = 72, 61.02%), and retried (n = 66, 55.93%). The mean value of outcome variables at baseline was: body weight = 69.43 ± 14.43 kg, GSLTPAQ = 14.43 ± 16.25, waist circumference = 95.68 ± 9.52 cm, systolic blood pressure (SBP) = 135.44 ± 14.44 mmHg, DBP = 82.81 ± 9.64 mmHg, total cholesterol = 4.69 ± 1.12 mmol/L, HDL cholesterol = 1.32 ± 0.32 mmol/L, LDL cholesterol = 2.53 ± 0.97 mmol/L, triacylglycerols = 1.73 ± 0.77 mmol/L, fasting blood sugar = 6.20 ± 1.50 mmol/L, 3-min step test = 4.19 ± 1.40, PSS-10 = 15.07 ± 5.43, SEE = 4.63 ± 1.87. Regarding the outcome variables at baseline, no significant difference was noted, except DBP. The mean DBP in the control group (79.05 ± 10.63 mmHg) was statistically lower than the app group (83.42 ± 10.17 mmHg) and booklet group (85.86 ± 6.77 mmHg).

3.2. Efficacy of Different Interventions on Outcome Variables at Follow-Ups

The GEE results of outcomes across T1, T2, T3, and T4 between three groups were summarized in Supplementary materials, Tables S1 and S2. Compared to the control group, the app group showed a significant effect on several outcomes that the body weight was reduced significantly (Figure 1; T3, β = −0.913, p = 0.040; T4, β = −1.254, p = 0.007). The changes in total exercise time per week, measured by GSLTPAQ, indicated that the app group could significantly increase in exercise time at all of the time points than the control group (Figure 2; T2, β = 11.647, p = 0.032; T3, β = 10.141, p = 0.041; T4, β = 11.784, p = 0.013). Regarding the waist circumference, both the booklet group and app group showed greater reductions than the control group (Figure 3). However, only the reduction in the app group was statistically and significantly different from the control group at T4 (β = −3.842, p < 0.001). Self-efficacy for exercise in the app group was improved significantly than the control group at T3 (β = 1.043, p = 0.037) and T4 (β = 1.170, p = 0.031), Figure 4. Regarding the comparison between the app group and booklet group (Table S2), results showed that the use of app could significantly increase total exercise time per week (T4, β =14.709, p = 0.001) and reduce waist circumference (T4, β = −2.688, p = 0.015).
Table 2 shows the effect size estimations of the app and booklet on the outcome variables at T4. As compared to the control group, the app group has better performance than the booklet group in most outcomes. The app group had a moderate-to-large effect to reduce body weight (Cohen’s d = −0.673), a large effect to reduce waist circumference (Cohen’s d = −1.197), and a small-to-moderate effect to improve total exercise time per week (GSLTPAQ, Cohen’s d = 0.495). Regarding the reduction of total cholesterol, compared to the control group, the booklet group (Cohen’s d = −0.421) showed a better effect than the app group (Cohen’s d = −0.349). On the other hand, the app group had no effect with regards to reducing stress (Cohen’s d = 0.038), but the booklet group had a small-to-moderate effect in terms of reducing stress (Cohen’s d = −0.344).

4. Discussion

To the best of our knowledge, this is the first analysis to evaluate the effect of theory-guided app and booklet versus control group among patients with hypertension and MetS in community. In the sub-group analysis of the three-arm RCT, the theory-guide MetS app could significantly increase the participant’s total exercise and self-efficacy to do exercise. As a result, their body weight and waist circumference were reduced significantly after 24 weeks. The MetS app had moderate-to-large effect on the reduction of body weight and waist circumference and small-to-moderate effect to improve total exercise time per week. Two systematic reviews reported that an e-health intervention with features of self-health monitoring, goal setting, and feedback would promote a behavior to become habit, such as doing more exercise and for a longer duration [21,27]. The membership area of the MetS app provides the forementioned features which may have further motivated the participant’s self-efficacy to do more exercise to reduce body weight and waist circumference.
Patients with hypertension and MetS did more exercises with the support of the MetS app. Two national studies found that patients with hypertension became physical inactive after the use of anti-hypertensive medication [28,29]. In addition to overweight and obesity, physical inactivity increases the likelihood of dyslipidemia, insulin resistance, and hypertension [30], which are the cardiometabolic risk factors of MetS [1]. By using the MetS app, patients with hypertension and MetS can be reversed from MetS to non-MetS as their body weight and waist circumference were reduced significantly. The change to non-MetS helps them to lower the chance of developing adverse cardiovascular events.
Except for waist circumference, no statistical significance was noted on other variables of cardiometabolic profile. In addition to the small number of participants in this secondary data analysis, the non-significant result might be attributable to the controlled values of the cardiometabolic profiles of the participants at baseline. The hypertension management guidelines indicated that the blood pressure for treated patients with hypertension should be controlled at SBP < 140 mmHg and DBP < 90 mmHg [10,11,12]. At baseline, the participants had already had a controlled blood pressure that might be difficult to detect significant change after the intervention. Regarding the blood analysis of cholesterols, the app might reduce the participant’s total cholesterol and LDL level and increase the HDL level. The non-significance results of cholesterols suggest an emphasis on healthy diet in the app in future. In turn, blood pressure and cholesterols are major predictors of cardiovascular risk [31]. The MetS app could potentially reduce the cardiovascular risk among patients with hypertension and MetS.
The GEE results showed that the participant’s stress level was decreased after the interventions. It was interesting that the reduction of stress in the booklet group was greater than that in the app group, compared to the control group. Furthermore, the booklet group showed a small-to-moderate effect to reduce stress. Although the content of stress management is included in both booklet and MetS app, the required digital competency in using the app might be another source of stressor [32]. In addition to one session to explain the use of app at the beginning, some follow-up calls or face-to-face sessions might be required to support the users proactively. On the other hand, the participants had already had a low level of stress at baseline. Future study can examine if the app and booklet are useful for patients at moderate or high level of stress.

4.1. Limitations

There are several limitations of this study. The sub-group analysis of a RCT and the groups for the current analysis were not generated by randomization and hence might have selection bias, although there was no statistical difference at baseline across groups. The small sample size was another limitation. Hence, only preliminary evidence is provided. Social desirability bias cannot not be compromised since several outcomes, including GSLTPAQ, PSS-10, and SEE, are self-reported. Step count device may be useful to provide objective measure of exercise. Female were dominant in this study, so the findings should be interpreted with caution. Lastly, this study is a secondary data analysis of a three-arm RCT and hence the conclusion of the results was preliminary. A full scale RCT for patients with hypertension and MetS is suggested for future research.

4.2. Implications

This study contributed to more evidence-based practice by examining the effect of a theory-guided intervention using a MetS app and a booklet versus a control group for patients with hypertension and MetS. The age of the participants indicated that the MetS app was suitable for older adults. The MetS app is important for MetS patients with obesity and hypertension, as these risks may be amenable due to our intervention. The educational intervention delivered by app could improve exercise self-efficacy, exercise amount leading to decreasing body weight, and waist circumference.

5. Conclusions

Patients with hypertension and MetS have a higher risk to develop adverse cardiovascular events yet amenable with life- style intervention. This study showed that the use of MetS app could significantly reduce their body weight and waist circumference and increase their exercise. The blood analysis of cholesterols was also improved. Considering the convenience, the app could be applied in the community care support to improve the patient outcomes.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijerph191912591/s1, Table S1: Results of generalized estimating equation analysis on outcome variables compared to the control group; Table S2: Results of generalized estimating equation analysis on outcome variables compared between the app group and booklet group.

Author Contributions

Conceptualization, E.M.L.W. and D.Y.P.L.; methodology, E.M.L.W. and D.Y.P.L.; formal analysis, D.Y.P.L. and H.L.T.; investigation, A.S.P.C. and K.C.C.; data curation, E.M.L.W. and K.C.C.; writing—original draft preparation, E.M.L.W. and H.L.T.; writing—review and editing, E.M.L.W., H.L.T., and D.Y.P.L.; supervision, E.M.L.W. and A.Y.M.L.; project administration, A.S.P.C. and K.C.C.; funding acquisition, D.Y.P.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Health and Medical Research Fund, grant number 16172411.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of the Hong Kong Polytechnic University (reference number: HSEARS20181211005).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study. The study has been registered at ClinicalTrials.gov Protocol Registration System with ID: NCT03778788.

Data Availability Statement

Data are available upon request.

Acknowledgments

The authors thank Health and Medical Research Fund, Food and Health Bureau of Hong Kong SAR for supporting their research from 2019–2021. Special thanks to the happy-retired.com for project promotion and the patients who participate in the project, especially during COVID-19 pandemic period.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. International Diabetes Federation. IDF Consensus Worldwide Definition of the Metabolic Syndrome. Available online: https://www.idf.org/component/attachments/attachments.html?id=705&task=download (accessed on 18 July 2022).
  2. Leung, L.Y.L.; Chan, S.M.N.; Tam, H.L.; Wong, E.S.W. Astaxanthin Influence on Health Outcomes of Adults at Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis. Nutrients 2022, 14, 2050. [Google Scholar] [CrossRef] [PubMed]
  3. Saklayen, M.G. The Global Epidemic of the Metabolic Syndrome. Curr. Hypertens. Rep. 2018, 20, 12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Lao, X.Q.; Ma, W.J.; Sobko, T.; Zhang, Y.H.; Xu, Y.J.; Xu, X.J.; Yu, D.M.; Nie, S.P.; Cai, Q.M.; Wei, X.L.; et al. Dramatic escalation in metabolic syndrome and cardiovascular risk in a Chinese population experiencing rapid economic development. BMC Public Health 2014, 14, 983. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Mottillo, S.; Filion, K.B.; Genest, J.; Joseph, L.; Pilote, L.; Poirier, P.; Rinfret, S.; Schiffrin, E.L.; Eisenberg, M.J. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J. Am. Coll. Cardiol. 2010, 56, 1113–1132. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Ranasinghe, P.; Mathangasinghe, Y.; Jayawardena, R.; Hills, A.P.; Misra, A. Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: A systematic review. BMC Public Health 2017, 17, 101. [Google Scholar] [CrossRef] [Green Version]
  7. Murray, C.J.L.; Aravkin, A.Y.; Zheng, P.; Abbafati, C.; Abbas, K.M.; Abbasi-Kangevari, M.; Abd-Allah, F.; Abdelalim, A.; Abdollahi, M.; Abdollahpour, I.; et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020, 396, 1223–1249. [Google Scholar] [CrossRef]
  8. Burnier, M.; Egan, B.M. Adherence in Hypertension. Circ. Res. 2019, 124, 1124–1140. [Google Scholar] [CrossRef]
  9. American Heart Association. What Is Metabolic Syndrome? Available online: https://www.heart.org/-/media/Files/Health-Topics/Answers-by-Heart/What-Is-Metabolic-Syndrome.pdf (accessed on 18 July 2022).
  10. Unger, T.; Borghi, C.; Charchar, F.; Khan, N.A.; Poulter, N.R.; Prabhakaran, D.; Ramirez, A.; Schlaich, M.; Stergiou, G.S.; Tomaszewski, M.; et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension 2020, 75, 1334–1357. [Google Scholar] [CrossRef]
  11. Williams, B.; Mancia, G.; Spiering, W.; Agabiti Rosei, E.; Azizi, M.; Burnier, M.; Clement, D.L.; Coca, A.; de Simone, G.; Dominiczak, A.; et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 2018, 39, 3021–3104. [Google Scholar] [CrossRef] [Green Version]
  12. Whelton, P.K.; Carey, R.M.; Aronow, W.S.; Casey, D.E.; Collins, K.J.; Dennison Himmelfarb, C.; DePalma, S.M.; Gidding, S.; Jamerson, K.A.; Jones, D.W.; et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2018, 71, e127–e248. [Google Scholar]
  13. Tam, H.L.; Wong, E.M.L.; Cheung, K. Effectiveness of Educational Interventions on Adherence to Lifestyle Modifications Among Hypertensive Patients: An Integrative Review. Int. J. Environ. Res. Public Health 2020, 17, 2513. [Google Scholar] [CrossRef] [PubMed]
  14. Wang, Q.; Chair, S.Y.; Wong, E.M.L. The effects of a lifestyle intervention program on physical outcomes, depression, and quality of life in adults with metabolic syndrome: A randomized clinical trial. Int. J. Cardiol. 2017, 230, 461–467. [Google Scholar] [CrossRef] [PubMed]
  15. Yamaoka, K.; Tango, T. Effects of lifestyle modification on metabolic syndrome: A systematic review and meta-analysis. BMC Med. 2012, 10, 138. [Google Scholar] [CrossRef] [PubMed]
  16. Ma, Y.; Cheng, H.Y.; Cheng, L.; Sit, J.W.H. The effectiveness of electronic health interventions on blood pressure control, self-care behavioural outcomes and psychosocial well-being in patients with hypertension: A systematic review and meta-analysis. Int. J. Nurs. Stud. 2019, 92, 27–46. [Google Scholar] [CrossRef]
  17. Wong, E.M.L.; Leung, D.Y.P.; Tam, H.L.; Wang, Q.; Yeung, K.W.; Leung, A.Y.M. The Effect of a Lifestyle Intervention Program Using a Mobile Application for Adults with Metabolic Syndrome, versus the Effect of a Program Using a Booklet: A Pilot Randomized Controlled Trial. Clin. Interv. Aging 2021, 16, 633–644. [Google Scholar] [CrossRef]
  18. Bassi, N.; Karagodin, I.; Wang, S.; Vassallo, P.; Priyanath, A.; Massaro, E.; Stone, N.J. Lifestyle modification for metabolic syndrome: A systematic review. Am. J. Med. 2014, 127, 1242.e1-10. [Google Scholar] [CrossRef]
  19. Jahangiry, L.; Montazeri, A.; Najafi, M.; Yaseri, M.; Farhangi, M. An interactive web-based intervention on nutritional status, physical activity and health-related quality of life in patients with metabolic syndrome: A randomized-controlled trial (The Red Ruby Study). Nutr. Diabetes 2017, 7, e240. [Google Scholar] [CrossRef] [Green Version]
  20. Wong, E.M.-L.; Leung, D.Y.P.; Chair, S.-Y.; Sit, J.W.H. Effects of a Web-Based Educational Support Intervention on Total Exercise and Cardiovascular Risk Markers in Adults With Coronary Heart Disease. Worldviews Evidence-Based Nurs. 2020, 17, 283–292. [Google Scholar] [CrossRef]
  21. Whitehead, L.; Seaton, P. The Effectiveness of Self-Management Mobile Phone and Tablet Apps in Long-term Condition Management: A Systematic Review. J. Med. Internet Res. 2016, 18, e97. [Google Scholar] [CrossRef]
  22. Wong, E.M.L.; Leung, D.Y.P.; Wang, Q.; Leung, A.Y.M. A nurse-led lifestyle intervention using mobile application versus booklet for adults with metabolic syndrome-Protocol for a randomized controlled trial. J. Adv. Nurs. 2020, 76, 364–372. [Google Scholar] [CrossRef]
  23. Godin, G. The Godin-Shephard Leisure-Time Physical Activity Questionnaire. Health Fit. J. Can. 2011, 4, 18–22. [Google Scholar]
  24. Leung, D.Y.P.; Lam, T.H.; Chan, S.S.C. Three versions of Perceived Stress Scale: Validation in a sample of Chinese cardiac patients who smoke. BMC Public Health 2010, 10, 513. [Google Scholar] [CrossRef] [PubMed]
  25. Lee, L.L.; Perng, S.J.; Ho, C.C.; Hsu, H.M.; Lau, S.C.; Arthur, A. A preliminary reliability and validity study of the Chinese version of the self-efficacy for exercise scale for older adults. Int. J. Nurs. Stud. 2009, 46, 230–238. [Google Scholar] [CrossRef] [PubMed]
  26. Cohen, J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed.; Erlbaum: Hillsdale, NJ, USA, 1988. [Google Scholar]
  27. LaPlante, C.; Peng, W. A Systematic Review of e-Health Interventions for Physical Activity: An Analysis of Study Design, Intervention Characteristics, and Outcomes. Telemed. e-Health 2011, 17, 509–523. [Google Scholar] [CrossRef]
  28. Korhonen, M.J.; Pentti, J.; Hartikainen, J.; Ilomaki, J.; Setoguchi, S.; Liew, D.; Kivimaki, M.; Vahtera, J. Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid-Lowering Medication: A Cohort Study. J. Am. Hear. Assoc. 2020, 9, e014168. [Google Scholar] [CrossRef]
  29. Tam, H.L.; Chung, S.F.; Wang, Q. Urban-rural disparities in hypertension management among middle-aged and older patients: Results of a 2018 Chinese national study. Chronic Illn. 2022. [Google Scholar] [CrossRef]
  30. World Health Organization. WHO Guidelines on Physical Activity and Sedentary Behaviour. Available online: https://apps.who.int/iris/bitstream/handle/10665/336656/9789240015128-eng.pdf (accessed on 20 July 2022).
  31. Goff, D.C., Jr.; Lloyd-Jones, D.M.; Bennett, G.; Coady, S.; D’Agostino, R.B.; Gibbons, R.; Greenland, P.; Lackland, D.T.; Levy, D.; O’Donnell, C.J.; et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014, 129, S49–S73. [Google Scholar] [CrossRef] [Green Version]
  32. Morrissey, E.C.; Casey, M.; Glynn, L.G.; Walsh, J.C.; Molloy, G.J. Smartphone apps for improving medication adherence in hypertension: Patients’ perspectives. Patient Prefer. Adher. 2018, 12, 813–822. [Google Scholar] [CrossRef]
Figure 1. Boxplot of the change of body weight at different time point among the groups.
Figure 1. Boxplot of the change of body weight at different time point among the groups.
Ijerph 19 12591 g001
Figure 2. Boxplot of the change of total exercise time per week at different time point among the groups.
Figure 2. Boxplot of the change of total exercise time per week at different time point among the groups.
Ijerph 19 12591 g002
Figure 3. Boxplot of the change of waist circumference at different time point among the groups.
Figure 3. Boxplot of the change of waist circumference at different time point among the groups.
Ijerph 19 12591 g003
Figure 4. Boxplot of the change of self-efficacy for exercise at different time point among the groups.
Figure 4. Boxplot of the change of self-efficacy for exercise at different time point among the groups.
Ijerph 19 12591 g004
Table 1. Characteristics of participants and outcome variables at baseline.
Table 1. Characteristics of participants and outcome variables at baseline.
VariablesApp Group
(n = 36)
Booklet Group
(n = 42)
Control Group
(n = 40)
p-Value
Age in years (SD)66.94 (10.51)64.07 (7.02)66.35 (10.04)0.344
Sex 0.156
Male15119
Female213131
Education level 0.09
Primary school or below9513
Secondary school162920
Tertiary education1187
Marital Status 0.113
Married252621
Not married764
Separated/Divorced/Widow41015
Employment status 0.207
Full-time job7610
Part-time job361
Housewife3106
Retired/Others232023
Financial status 0.118
Good737
Average233422
Poor6511
Residential status 0.106
Live alone51114
Live with family313126
Smoking status 0.607
Current smoker001
Quitted364
Never smoked333635
Outcome variables (SD)
Body weight67.01 (12.76)71.06 (14.88)69.91 (15.41)0.455
GSLTPAQ17.18 (11.14)18.07 (17.69)16.97 (18.72)0.949
Waist circumference93.51 (8.30)96.99 (10.44)96.25 (9.41)0.247
Systolic blood pressure136.83 (15.07)136.85 (14.51)132.70 (13.76)0.339
Diastolic blood pressure83.42 (10.17)85.86 (6.77)79.05 (10.63)0.004
Total cholesterol4.68 (1.11)4.91 (1.27)4.49 (0.93)0.233
HDL cholesterol1.36 (0.33)1.35 (0.34)1.39 (0.31)0.846
LDL cholesterol2.55 (0.98)2.70 (1.02)2.32 (0.91)0.213
Triacylglycerols1.65 (0.77)1.85 (0.82)1.67 (0.72)0.443
Fasting blood sugar5.97 (0.70)6.21 (1.43)6.39 (2.02)0.465
3-min step test4.19 (1.39)3.95 (1.28)4.45 (1.53)0.281
Perceived stress scale13.58 (5.54)15.66 (4.54)15.77 (6.02)0.143
Self-efficacy for exercise scale4.95 (1.81)4.24 (1.71)4.76 (2.04)0.21
GSLTPAQ = Godin-Shephard Leisure-Time Physical Activity Questionnaire, HDL = high density lipoprotein, LDL = low density lipoprotein.
Table 2. Comparing the effects of the app and booklet group at week 24.
Table 2. Comparing the effects of the app and booklet group at week 24.
VariablesCohen’s d
App vs. ControlBooklet vs. ControlApp vs. Booklet
Body weight−0.673−0.294−0.360
Godin-Shephard Leisure-Time Physical Activity Questionnaire 0.495−0.0740.910
Waist circumference−1.197−0.488−0.587
Systolic blood pressure−0.0050.009−0.012
Diastolic blood pressure−0.156−0.2960.111
Total cholesterol−0.349−0.4210.038
High density lipoprotein (HDL) cholesterol0.022−0.2410.239
Low density lipoprotein (LDL) cholesterol−0.727−0.248−0.310
Triacylglycerols0.3010.0900.160
Fasting blood sugar0.1770.1510.056
3-min step test0.0150.027−0.011
Perceived stress scale0.038−0.3440.600
Self-efficacy for exercise scale0.2560.1180.173
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Wong, E.M.L.; Tam, H.L.; Leung, A.Y.M.; Cheung, A.S.P.; Cheung, K.C.; Leung, D.Y.P. Impacts of Educational Interventions with Support of Mobile App versus Booklet for Patients with Hypertension and Metabolic Syndrome: A Secondary Data Analysis. Int. J. Environ. Res. Public Health 2022, 19, 12591. https://doi.org/10.3390/ijerph191912591

AMA Style

Wong EML, Tam HL, Leung AYM, Cheung ASP, Cheung KC, Leung DYP. Impacts of Educational Interventions with Support of Mobile App versus Booklet for Patients with Hypertension and Metabolic Syndrome: A Secondary Data Analysis. International Journal of Environmental Research and Public Health. 2022; 19(19):12591. https://doi.org/10.3390/ijerph191912591

Chicago/Turabian Style

Wong, Eliza Mi Ling, Hon Lon Tam, Angela Yee Man Leung, Alice Siu Ping Cheung, Ka Ching Cheung, and Doris Yin Ping Leung. 2022. "Impacts of Educational Interventions with Support of Mobile App versus Booklet for Patients with Hypertension and Metabolic Syndrome: A Secondary Data Analysis" International Journal of Environmental Research and Public Health 19, no. 19: 12591. https://doi.org/10.3390/ijerph191912591

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop